As Seasonal Flu Ramps Up, NexBio Begins Phase II Trial for DAS181
DAS181 is formulated to prevent the influenza virus from entering cells in the respiratory tract.
DAS181 is formulated to prevent the influenza virus from entering cells in the respiratory tract.
Copyright © 2024 | WordPress Theme by MH Themes